Heinrich Gerding
0000-0003-3968-5601
4 papers found
Refreshing results…
Sustained Benefits of Ranibizumab with or without Laser in Branch Retinal Vein Occlusion
Intraocular use of acid violet 17 at a concentration of 1.5 mg/ml is not safe
Individualized Stabilization Criteria–Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion
Individualized Ranibizumab Regimen Driven by Stabilization Criteria for Central Retinal Vein Occlusion
Missing publications? Search for publications with a matching author name.